Point-of-Care Diagnostics: Technologies and Global Markets

The global market for point of care diagnosis should grow from $24.8 billion in 2021 to $43.5 billion by 2026 with a compound annual growth rate (CAGR) of 11.9% for the period of 2021-2026.

Report Includes

• 59 data tables and 40 additional tables
• An overview of the global markets and technologies for point of care (POC) diagnostics within healthcare industry
• Estimation of market size and analyses of global market trends, with data from 2019, 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
• Evaluation of current market trends, and technological advancements within the industry and market share analysis by test type, product, end user, and region
• Coverage of novel approaches for the POC; discussion on significance of CLIA in the United States and FDA’s role in POC testing; and information on laser PCR
• Detailed description about COVID-19 impact on MedTech and medical tourism, discussion on FDA’s contribution to COVID-19 diagnostic testing and synopsis of FDA-Associated testing milestones since May 2020
• Detailed analysis of relevant R&D activities, new products launches and product enhancement in the industry, clinical trials, and discussion of regulatory elements that are affecting the future marketplace
• Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
• Company profiles of major players of the industry, including Abbott, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Medtronic plc, Chembio Diagnostics Inc. and Philips Healthcare

The global market for point of care (POC) diagnostics and testing should grow from $19.3 billion in 2018 to $25.5 billion by 2023 with a compound annual growth rate (CAGR) of 5.7% from 2018 to 2023.

Report Includes

• 43 data tables and 19 additional tables
• An overview of the global markets for point of care (POC) diagnostics and testing within healthcare industry
• Analyses of global market trends, with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
• A look at the diagnostic testing industry featuring current trends, government regulations and growth drivers that will shape the future POC testing market
• Assessment of competitive landscape and current product suppliers and some of their technologies and market shares within the POC industry
• Patent study and analysis covering all significant developments in POC technologies
• Company profiles of major global players within the POC market, including Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Co., Danaher Corp., Roche and Siemens Medical Solutions

The global point of care (POC) diagnostics market was valued at nearly $16.8 billion and $18.0 billion in 2014 and 2015, respectively. This market is expected to grow from $19.3 billion in 2016 to $28.3 billion in 2021 at a compound annual growth rate (CAGR) of 8.0% for 2016-2021.

Report Includes

• An overview of the global markets for point of care diagnostics.
• Analyses of global market trends, with data from 2014 and 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
• Discussion of factors driving the market including staff shortages, older populations, long-term cost savings, and need for faster diagnosis and care.
• A look at how availability of POC testing has revolutionized the continuum of the patient-care process.
• In depth analysis of the major force driving the growth of this industry, the effort to provide better patient care by improving the turn-around-time (TAT) that POC testing offers.
• A look at the other market factors including growth restraints and opportunities.
• Profiles of major players in the industry.

BCC Research estimates the global market for point-of-care (POC) diagnostics to have been almost $15.1 billion in 2012. The market should reach $15.5 billion in 2013 and $19.3 billion in 2018, a compound annual growth rate (CAGR) of 4.5% over the next five years.

Report Includes

• An overview of the global market for point of care diagnostics.
• Analyses of global market trends, with data from 2012 and 2013, and estimates and projections of CAGRs through 2018.
• Discussion of factors driving the market including staff shortages, older populations, long-term cost savings, and need for faster diagnosis and care.
• A look at how availability of POC testing has revolutionized the continuum of the patient-care process.

The global point-of-care (POC) diagnostics market reached $13.4 billion in 2010 and is expected to reach $13.8 billion in 2011. It will further grow to $16.5 billion in 2016 for a compound annual growth rate (CAGR) of 3.7% between 2011 and 2016.

• Global POC market was worth nearly $13.4 billion in 2009, it is estimated to increase to $18.7 billion, at 5 year compound annual growth rate (CAGR) of 7.0%.
• The largest test blood chemistry and electrolyte market was nearly $2.1 billion in 2009. This is expected to rise to $3.8 billion in 2014, at a CAGR of 12.0%.
• Glucose monitoring test market reached approximately $7.7 million in 2009 and is projected to reach $9.9 billion in 2014, at a CAGR of 5.1%.

• POC testing revenue reached an estimated $5.05 billion in 2005 and is expected to grow at a 13.8% AAGR through 2010, yielding sales of nearly $9.65 billion.
• A major force driving the growth of this industry is the effort to provide better patient care by improving the time to treatment (TAT) that POC testing offers. Other forces include cost containment, the aging population, the increased incidence of certain diseases, and technological advances.
• Glucose testing meters and supplies accounted for 47.9% of POC sales in 2005 and are expected to grow at a 9.4% AAGR through 2010. The worldwide incidence of diabetes is predicted to double in the next 25 years.